The FDA announced on May 21, 2013, that Baxter Healthcare Corp. recalled Sodium Chloride Injection, USP, due to a lack of sterility assurance caused by potential administration port leakage. The agency classified the recall as Class II.
How to tell if you have it
- Brand: Baxter
- Product: Sodium Chloride Injection Viaflex
- Product code 2B1301- 50 mL in Viaflex Container Quad Pack (NDC 0338-0049-11)
- Product code 2B1302- 100mL in Viaflex Quad Pack (NDC 0338-0049-18)
- Product code 2B1306- 50 mL in Viaflex Single Pack (NDC 0338-0049-41)
- Product code 2B1307- 100mL in Viaflex Single Pack (NDC 0338-0049-48)
- Product code 2B1308- 50 ML in Viaflex Multi Pack (NDC 0338-0049-31)
- Product code 2B1309- 100mL in Viaflex Multi Pack (NDC 0338-0049-38)
- Lot codes: P279943, P280370, P280248, P280248A, P280248B, P285346, P285791, P285601, P280347, P280404, P280404A, P285635, P285858, P280149
- Distribution: Nationwide & Puerto Rico
The hazard
According to the FDA, specific lot numbers of these products have been identified for potential administration port leakage resulting from a manufacturing issue during the sealing of the closure assembly. This defect creates a lack of assurance of sterility for the Sodium Chloride Injection, USP.
Context
GovInfoNow's records show Baxter Healthcare Corp. has 34 other recalls on record since September 21, 2012. Other recent recalls of similar products include Baxter Amia Dialysis Set Recall (September 1, 2017), Baxter Recalls Brevibloc Injection Due to Discoloration (April 12, 2016), and Baxter Recalls Sodium Chloride Irrigation Due to Insect Contamination (February 5, 2016). Additional recent recalls include Baxter Vasopressin Injection Recall (August 6, 2026), Baxter 0.9% Sodium Chloride Injection Recall (August 17, 2026), and Huons Co. 10mL Sodium Chloride Injection Recall (April 2, 2026).